600211.SH
Tibet Rhodiola Pharmaceutical Holding Co.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 35.99
+0.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.37x
- PEG TTM
- 1.04x
- Price / book
- 3.27x
- Price / sales
- 3.85x
- Price / cash flow
- 10.67x
Enterprise value
- Enterprise value
- CNY 10.1B
- EV / sales
- 3.36x
- EV / EBITDA
- 8.96x
- EV / EBIT
- 9.52x
- Market cap
- CNY 11.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026